An over-the-counter (“OTC”) pharmaceutical company with multi-market applications for our revolutionary targeted drug delivery system which is identified as QuantaSphere® Technology (QS®). We currently hold 29 issued patents and have an additional 15 patent applications pending. Our technology places OTC drugs, pharmaceuticals, and chemicals into micro-sized, electrostatically charged encapsulates as well as into other types of micro-encapsulates. These encapsulates are then suspended in uniquely designed formulations.
Lead Underwriter
Craft Capital Management LLC, R.F. Lafferty & Co., Inc
